NMPA Approval

Recombinant Hepatitis B Vaccine (CHO Cell)

Approval Number

国药准字S20103001

Company华北制药金坦生物技术股份有限公司

Registration Date

February 5, 2021

Drug Information

Generic Name

重组乙型肝炎疫苗(CHO细胞)

Dosage Form

注射剂

Strength

10μg/0.5ml

Drug Type

生物制品

Registration Date

February 5, 2021

Company Information

Applicant Company

Company Name华北制药金坦生物技术股份有限公司

Company Address

石家庄高新区天山南大街106号

Manufacturing Company

Company Name华北制药金坦生物技术股份有限公司

Company Address

石家庄高新区天山南大街106号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

重组乙型肝炎疫苗(CHO细胞) - NMPA 批准文号 | MedPath